{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:08:40Z","timestamp":1775545720809,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI11247"],"award-info":[{"award-number":["K23AI11247"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2 TR001103"],"award-info":[{"award-number":["KL2 TR001103"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"QIAGEN"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1901-8","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T13:32:21Z","timestamp":1476279141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA"],"prefix":"10.1186","volume":"16","author":[{"given":"Ank E.","family":"Nijhawan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Princess A.","family":"Iroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Winetsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmaeil","family":"Porsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"1901_CR1","volume-title":"Reported Tuberculosis in the United States, 2013","author":"CDC","year":"2014","unstructured":"CDC. Reported Tuberculosis in the United States, 2013. Atlanta: Department of Health and Human Services, CDC; 2014."},{"key":"1901_CR2","volume-title":"Trends alert: corrections health care costs","author":"C Kinsella","year":"2004","unstructured":"Kinsella C. Trends alert: corrections health care costs. Lexington: The Council for State Governments; 2004."},{"issue":"2","key":"1901_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.amepre.2005.10.018","volume":"30","author":"CA Roberts","year":"2006","unstructured":"Roberts CA, Lobato MN, Bazerman LB, Kling R, Reichard AA, Hammett TM. Tuberculosis prevention and control in large jails: a challenge to tuberculosis elimination. Am J Prev Med. 2006;30(2):125\u201330.","journal-title":"Am J Prev Med"},{"issue":"1","key":"1901_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1128\/CVI.13.1.53-58.2006","volume":"13","author":"E Porsa","year":"2006","unstructured":"Porsa E, Cheng L, Seale MM, Delclos GL, Ma X, Reich R, Musser JM, Graviss EA. Comparison of a new ESAT-6\/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol. 2006;13(1):53\u20138.","journal-title":"Clin. Vaccine Immunol"},{"issue":"7","key":"1901_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.5588\/ijtld.13.0816","volume":"18","author":"IS Schwartz","year":"2014","unstructured":"Schwartz IS, Bach PJ, Roscoe B, Majury A, Hopman WM, Ellis E, Garrahan T, Smith J, Barkley R, Panaro L, et al. Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates. Int J Tuberc Lung Dis. 2014;18(7):787\u201392.","journal-title":"Int. J. Tuberc. Lung Dis"},{"issue":"1","key":"1901_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1183\/09031936.00115110","volume":"37","author":"R Diel","year":"2011","unstructured":"Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37(1):88\u201399.","journal-title":"Eur. Respir. J"},{"issue":"1","key":"1901_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1378\/chest.11-3157","volume":"142","author":"R Diel","year":"2012","unstructured":"Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest. 2012;142(1):63\u201375.","journal-title":"Chest"},{"issue":"Rr-5","key":"1901_CR8","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010;59(Rr-5):1\u201325.","journal-title":"MMWR Recomm. Rep"},{"issue":"5","key":"1901_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","volume":"184","author":"BP Linas","year":"2011","unstructured":"Linas BP, Wong AY, Freedberg KA, Horsburgh Jr CR. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2011;184(5):590\u2013601.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1901_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","volume":"169","author":"MA de Perio","year":"2009","unstructured":"de Perio MA, Tsevat J, Roselle GA, Kralovic SM, Eckman MH. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med. 2009;169(2):179\u201387.","journal-title":"Arch Intern Med"},{"issue":"10","key":"1901_CR11","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1017\/S0950268812002907","volume":"141","author":"A Kowada","year":"2013","unstructured":"Kowada A. Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons. Epidemiol Infect. 2013;141(10):2224\u201334.","journal-title":"Epidemiol Infect"},{"key":"1901_CR12","unstructured":"QuantiFERON-TB Gold [Package insert] [ http:\/\/usa.quantiferon.com\/irm\/content\/PI\/QFT\/2PK\/US.pdf ]. Accessed 2 Dec 2015."},{"issue":"3","key":"1901_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1164\/rccm.200701-057OC","volume":"177","author":"DE Bennett","year":"2008","unstructured":"Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, McQuillan GM, Lewis B, Navin TR, Castro KG. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000. Am J Respir Crit Care Med. 2008;177(3):348\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1901_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1183\/09031936.00114810","volume":"37","author":"M Sester","year":"2011","unstructured":"Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2011;37(1):100\u201311.","journal-title":"Eur. Respir. J"},{"issue":"1","key":"1901_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","volume":"189","author":"SE Dorman","year":"2014","unstructured":"Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014;189(1):77\u201387.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1901_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1378\/chest.11-0992","volume":"142","author":"KS Fong","year":"2012","unstructured":"Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, Gordon SM, Miranda C. Challenges of interferon-gamma release assay conversions in serial testing of health-care workers in a TB control program. Chest. 2012;142(1):55\u201362.","journal-title":"Chest"},{"issue":"11","key":"1901_CR17","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1128\/JCM.01627-13","volume":"51","author":"RL Gaur","year":"2013","unstructured":"Gaur RL, Pai M, Banaei N. Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay. J Clin Microbiol. 2013;51(11):3521\u20136.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"1901_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1155\/2012\/576324","volume":"19","author":"M Joshi","year":"2012","unstructured":"Joshi M, Monson TP, Woods GL. Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States. Can Respir J. 2012;19(2):84\u20138.","journal-title":"Can Respir J"},{"key":"1901_CR19","unstructured":"Transitioning from TST to IGRA Testing in Ohio Prisons. [ http:\/\/centerfortuberculosis.mayo.edu\/uploads\/7\/1\/7\/3\/71735537\/_weiss_corrections.potx.pdf ]. Accessed 7 Oct 2016."},{"issue":"3","key":"1901_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1086\/595695","volume":"30","author":"P Vinton","year":"2009","unstructured":"Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA. Comparison of QuantiFERON-TB Gold in-tube test and tuberculin skin test for identification of latent mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol. 2009;30(3):215\u201321.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"1901_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.5588\/ijtld.10.0650","volume":"15","author":"P Weinfurter","year":"2011","unstructured":"Weinfurter P, Blumberg HM, Goldbaum G, Royce R, Pang J, Tapia J, Bethel J, Mazurek GH, Toney S, Albalak R. Predictors of discordant tuberculin skin test and QuantiFERON(R)-TB Gold In-Tube results in various high-risk groups. Int J Tuberc Lung Dis. 2011;15(8):1056\u201361.","journal-title":"Int. J. Tuberc. Lung Dis"},{"issue":"3","key":"1901_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177\u201384.","journal-title":"Ann Intern Med"},{"issue":"18","key":"1901_CR23","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1097\/QAD.0b013e3283188415","volume":"22","author":"C Stephan","year":"2008","unstructured":"Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, Rakus Z, Gottschalk R, Stark S, Brodt HR, et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS (London, England). 2008;22(18):2471\u20139.","journal-title":"AIDS (London, England)"},{"issue":"11","key":"1901_CR24","first-page":"1190","volume":"11","author":"S Jones","year":"2007","unstructured":"Jones S, de Gijsel D, Wallach FR, Gurtman AC, Shi Q, Sacks H. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. Int J Tuberc Lung Dis. 2007;11(11):1190\u20135.","journal-title":"Int. J. Tuberc. Lung Dis"},{"key":"1901_CR25","unstructured":"Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Mycobacterium tuberculosis Infection and Disease. In.; 2013."},{"key":"1901_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1472-6963-11-247","volume":"11","author":"A Nienhaus","year":"2011","unstructured":"Nienhaus A, Schablon A, Costa JT, Diel R. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res. 2011;11:247.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"1901_CR27","doi-asserted-by":"publisher","first-page":"e36551","DOI":"10.1371\/journal.pone.0036551","volume":"7","author":"M Shah","year":"2012","unstructured":"Shah M, DiPietro D, Greenbaum A, Ketemepi S, Martins-Evora M, Marsiglia V, Dorman SE. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. PLoS One. 2012;7(5):e36551.","journal-title":"PLoS One"},{"issue":"2","key":"1901_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jhin.2014.10.002","volume":"89","author":"A Kowada","year":"2015","unstructured":"Kowada A, Takasaki J, Kobayashi N. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries. J Hosp Infect. 2015;89(2):99\u2013108.","journal-title":"J. Hosp. Infect"},{"issue":"9","key":"1901_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/apc.2010.0102","volume":"24","author":"AK Person","year":"2010","unstructured":"Person AK, Goswami ND, Bissette DJ, Turner DS, Baker AV, Gadkowski LB, Naggie S, Erlandson K, Chen L, Lalani T, et al. Pairing QuantiFERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern United States. AIDS Patient Care STDs. 2010;24(9):539\u201343.","journal-title":"AIDS Patient Care STDs"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1901-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T12:09:23Z","timestamp":1692533363000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1901-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1901-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]},"assertion":[{"value":"12 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"564"}}